BioLine RX Ltd (NASDAQ:BLRX)

0.67
Delayed Data
As of Nov 20
 +0.03 / +4.69%
Today’s Change
0.64
Today|||52-Week Range
1.84
-38.53%
Year-to-Date
No recent news for BioLine RX Ltd.

Today’s Trading

Previous close0.64
Today’s open0.69
Day’s range0.65 - 0.70
Volume743,498
Average volume (3 months)993,625
Market cap$76.1M
Data as of 4:00pm ET, 11/20/2018

Growth & Valuation

Earnings growth (last year)+3.20%
Earnings growth (this year)--
Earnings growth (next 5 years)-25.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.33

Competitors

 Today’s
change
Today’s
% change
CKPTCheckpoint Therapeut...-0.08-3.43%
GNMXAevi Genomic Medicin...-0.03-2.80%
INFIInfinity Pharmaceuti...-0.05-3.55%
OTICOtonomy Inc+0.03+1.28%
Data as of 4:00pm ET, 11/20/2018

Financials

Next reporting dateMarch 20, 2019
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$0.00
Annual profit (last year)-$24.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Head-Investor Relations
Philip Adam Serlin
Chief Financial Officer
Mali Zeevi
Corporate headquarters
Modi'in, Tel Aviv

Forecasts